Marrero-Gonzalez Alejandro R, Nanu Douglas P, Nguyen Shaun A, Brennan Emily A, Albergotti William Greer, Chera Bhisham S, Harper Jennifer L, Kaczmar John M, Kejner Alexandra E, Newman Jason G, Skoner Judith M, Graboyes Evan M
Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
MUSC Libraries, Medical University of South Carolina, Charleston, South Carolina, USA.
Otolaryngol Head Neck Surg. 2025 Apr;172(4):1177-1191. doi: 10.1002/ohn.1113. Epub 2025 Jan 5.
The Hispanic health paradox (HHP), the observation that Hispanic people in the United States often experience better health outcomes than non-Hispanic people despite having worse prognostic factors, has not been evaluated for patients with head and neck squamous cell carcinoma (HNSCC), a malignancy with marked racial disparities in outcomes. The objective of this study is to evaluate the HHP within the context of HNSCC.
CINAHL, PubMed, and Scopus.
Studies that compared survival between Hispanic and non-Hispanic patients with HNSCC in the United States were included. Meta-analysis of adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs) was conducted to compare overall survival (OS) and cancer-specific survival (CSS) between Hispanic white (HW) and non-Hispanic white (NHW) patients with HNSCC.
Of 2106 unique abstracts reviewed, 25 studies were included in the systematic review and 22 in the meta-analysis. Among the 657,185 patients in the meta-analysis, 6.9% (95% CI: 5.8%-8.3%) were of Hispanic ethnicity. HW patients had improved OS relative to NHW patients (aHR = 0.90, 95% CI: 0.86-0.94) among the 17 studies reporting OS and improved CSS relative to NHW patients (aHR = 0.87, 95% CI: 0.80-0.94) among the 4 studies reporting this outcome.
HW people with HNSCC exhibit improved survival relative to NHW people with HNSCC, supporting the HHP in the context of HNSCC. Research is needed to understand the underlying mechanisms, which could provide insights into improving outcomes for all patients with HNSCC.
西班牙裔健康悖论(HHP)指的是,在美国,尽管西班牙裔人群的预后因素较差,但他们的健康结局往往优于非西班牙裔人群。头颈部鳞状细胞癌(HNSCC)是一种在治疗结果上存在显著种族差异的恶性肿瘤,目前尚未对其患者进行过西班牙裔健康悖论的评估。本研究的目的是在HNSCC的背景下评估HHP。
护理学与健康领域数据库(CINAHL)、医学期刊数据库(PubMed)和文摘与引文数据库(Scopus)。
纳入比较美国西班牙裔和非西班牙裔HNSCC患者生存率的研究。对调整后的风险比(aHRs)及95%置信区间(CIs)进行荟萃分析,以比较西班牙裔白人(HW)和非西班牙裔白人(NHW)HNSCC患者的总生存期(OS)和癌症特异性生存期(CSS)。
在审查的2106篇独特摘要中,25项研究纳入系统评价,22项纳入荟萃分析。在荟萃分析的657,185例患者中,6.9%(95%CI:5.8%-8.3%)为西班牙裔。在17项报告OS的研究中,HW患者相对于NHW患者的OS有所改善(aHR = 0.90,95%CI:0.86-0.94);在4项报告该结果的研究中,HW患者相对于NHW患者的CSS有所改善(aHR = 0.87,95%CI:0.80-0.94)。
与NHW的HNSCC患者相比,HW的HNSCC患者生存率更高,这支持了HNSCC背景下的HHP。需要开展研究以了解其潜在机制,这可能为改善所有HNSCC患者的治疗结果提供思路。